Schedule 13D ownership disclosure

Syndax Pharmaceuticals Inc

Security class unavailable · CUSIP: 87164F105

Event date: 2022-02-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-066275
Form type
SC 13D/A
Filer
Access Industries Holdings LLC
CIK
CIK 1391297
Filed
Mar 04, 2022
Reporting period
Feb 25, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub